Alpha-Lipoic Acid Nanoparticles via Metal Salt Coating
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
α-Lipoic acid is poorly soluble in water, unstable to heat and light, and has a strong sulfurous odor, making it challenging to formulate into stable products for pharmaceutical, cosmetic, and food applications.
Innovation Solution
Stable α-lipoic acid nanoparticles are produced by using a nonionic surfactant, a divalent metal ion, and a carbonate or phosphate ion, forming spherical or oval-shaped micelles that are coated with a polyvalent metal inorganic salt, enhancing solubility and stability while suppressing the sulfurous odor.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If α-lipoic acid is used in water-soluble preparations, then its antioxidant and chelating functions are achieved, but its poor water solubility and instability to heat and light prevent stable formulation
Solution Approach 1:
The patent uses a polyvalent metal inorganic salt (such as calcium carbonate, magnesium carbonate, or zinc phosphate) as an intermediary substance that forms nanoparticles with α-lipoic acid. This intermediary carrier system improves water solubility and stability while maintaining the antioxidant and chelating functions of α-lipoic acid, directly resolving the formulation stability issue.
Solution Approach 2:
The patent changes the physical form of α-lipoic acid from conventional bulk form to nanoparticle form with controlled particle size (0.1-10 μm). This parameter change in size and morphology significantly improves water solubility and thermal stability, allowing stable formulation in aqueous preparations without requiring special storage conditions.
2Reliability
If α-lipoic acid is used in high concentrations to achieve therapeutic effects, then antioxidant and chelating effects are enhanced, but the sulfurous odor becomes stronger and product quality deteriorates
Solution Approach 1:
The patent segments the α-lipoic acid into nanoparticle form, distributing the substance at the nanoscale level. This segmentation allows high total concentration for therapeutic effectiveness while the nanoparticle structure prevents aggregation that causes strong sulfurous odor, thus resolving the contradiction between effectiveness and odor control.
Solution Approach 2:
The patent creates a composite nanoparticle system combining α-lipoic acid with polyvalent metal inorganic salts. This composite structure maintains the biological activity and antioxidant effects of α-lipoic acid at high concentrations while the metal salt coating suppresses the sulfurous odor and improves overall product quality and after-use feel.
3Ease of manufacture
If emulsification methods are used to improve water solubility, then dispersibility is enhanced, but the emulsified state becomes easily separable when particle size is large
Solution Approach 1:
The patent fundamentally changes the particle size parameter from conventional emulsion sizes to nanoparticle range (0.1-10 μm). This size reduction dramatically improves water dispersibility and prevents phase separation, achieving both ease of manufacture and long-term stability without requiring complex emulsifying equipment or agents.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nanoparticles achieve high encapsulation efficiency, are transparently dispersed in water, and provide a sustained release effect, improving product stability and odor control.
Implementation Method 1
using a nonionic surfactant, a divalent metal ion, and a carbonate or phosphate ion, forming spherical or oval-shaped micelles
Implementation Method 2
coated with a polyvalent metal inorganic salt, enhancing solubility and stability while suppressing the sulfurous odor
Implementation Method 3
provide a sustained release effect, improving product stability and odor control
Data Source
AI summary
Provision of a stable α-lipoic acid. A method for producing α-lipoic acid nanoparticles, the method comprising the steps of: preparing an aqueous dispersion liquid containing α-lipoic acid and a nonionic surfactant; adding a divalent metal salt into the aqueous dispersion liquid, wherein the divalent metal salt is a divalent metal halide, a divalent metal acetate or a divalent metal gluconate; and adding an alkali metal carbonate or an alkali metal phosphate into the aqueous dispersion liquid which has been added with the divalent metal salt, thereby forming α-lipoic acid nanoparticles.